Medicare is expanding its coverage to include certain obesity drugs, including GLP-1 weight-loss medications. The new coverage may include a program offering these medications for $50 per month, although some reports suggest that patients may still face barriers to accessing these drugs. The specifics of the coverage and eligibility requirements are being outlined for beneficiaries, with the program reportedly launching as early as July.